罕见病重症肌无力治疗破局：全球首款FcRn拮抗剂在中国上市

七印授权

3S4SZNBGKAAARYCXO7A5AYD9MVZZGF242QB2RNP10P767FIKTQ

2023-09-06 09:45:09

article

5F5222A1B91F61FB949007088ACAD9E26B1530BE3E57AA0A5E4C2EC47CE63684

zh-CN

810C6AC3DBE42EC737C2BFAC2D1B6C124E284D4A

15203703

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

8fc1213e42275129be4bfe19e1a03c349f5888175c4cab755a37480ccc659c1026c509e058290af1436a22c1116b56b576798756ef81752080e33c66cfdfffbd1c

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"300000"},"type":"cm"}

yuanben_64f84a25b09343.45894253

原本认证

2AQYQDC3HW96IPTR6904B20MZNMHXNPNSP7NNIHIQI7W8E9FI5

https://www.yuanben.io/article/e2ec4f67-bacc-4f11-85a6-26db6047197d

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}